Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,442.80
(
0.00%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
98.48
(
-1.38%
)
Bitcoin
70,752.00
(
-0.03%
)
News Focus
News Focus
Post# of 257392
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122862
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rwdm post# 187061

Thursday, 09/03/2015 10:16:54 AM

Thursday, September 03, 2015 10:16:54 AM

Post# of 257392
PFE closes HSP acquisition:

http://finance.yahoo.com/news/pfizer-completes-acquisition-hospira-130000829.html

Pfizer continues to expect the transaction to be immediately accretive to adjusted diluted EPS1 upon closing, and accretive by $0.10 - $0.12 per share in the first full year after the close, with additional accretion anticipated thereafter. In addition, Pfizer expects the transaction will deliver $800 million in annual cost synergies by 2018.

Pfizer intends to update its 2015 financial guidance in the coming weeks to incorporate Hospira.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today